Hsiaopei Mok

656 total citations
26 papers, 382 citations indexed

About

Hsiaopei Mok is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Hsiaopei Mok has authored 26 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Hsiaopei Mok's work include Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Hsiaopei Mok is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Advanced Breast Cancer Therapies (4 papers) and Breast Cancer Treatment Studies (4 papers). Hsiaopei Mok collaborates with scholars based in China, United States and Lebanon. Hsiaopei Mok's co-authors include Bo Chen, Guochun Zhang, Ning Liao, Chongyang Ren, Yulei Wang, Lingzhu Wen, Cheukfai Li, Jianguo Lai, Li Cao and Guangnan Wei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Cochrane Database of Systematic Reviews.

In The Last Decade

Hsiaopei Mok

25 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsiaopei Mok China 12 147 144 131 94 62 26 382
Elizabeth C. O’Quinn United States 9 89 0.6× 95 0.7× 218 1.7× 82 0.9× 41 0.7× 14 478
W. Shannon Orr United States 8 129 0.9× 109 0.8× 198 1.5× 123 1.3× 87 1.4× 24 421
Maj‐Lis Talman Denmark 12 169 1.1× 100 0.7× 64 0.5× 31 0.3× 108 1.7× 23 409
Young-Joon Ryu South Korea 10 63 0.4× 102 0.7× 128 1.0× 65 0.7× 117 1.9× 29 359
Chengjuan Fan China 11 133 0.9× 112 0.8× 162 1.2× 111 1.2× 99 1.6× 28 437
Mengzhu Lv China 11 104 0.7× 74 0.5× 161 1.2× 47 0.5× 71 1.1× 23 364
Kevin Anton United States 8 52 0.4× 78 0.5× 106 0.8× 51 0.5× 60 1.0× 17 405
Simon F. Leicht Germany 9 80 0.5× 228 1.6× 335 2.6× 33 0.4× 74 1.2× 14 574
Zhilan Xiao China 13 114 0.8× 326 2.3× 177 1.4× 196 2.1× 116 1.9× 21 651

Countries citing papers authored by Hsiaopei Mok

Since Specialization
Citations

This map shows the geographic impact of Hsiaopei Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiaopei Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiaopei Mok more than expected).

Fields of papers citing papers by Hsiaopei Mok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiaopei Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiaopei Mok. The network helps show where Hsiaopei Mok may publish in the future.

Co-authorship network of co-authors of Hsiaopei Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiaopei Mok. A scholar is included among the top collaborators of Hsiaopei Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiaopei Mok. Hsiaopei Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liao, Ning, Cheukfai Li, Li Cao, et al.. (2022). Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node. Breast Cancer. 30(1). 77–87. 3 indexed citations
3.
Cao, Li, Chongyang Ren, Guochun Zhang, et al.. (2022). Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer. DNA and Cell Biology. 41(5). 521–538. 5 indexed citations
4.
Li, Cheukfai, Chongyang Ren, Lingzhu Wen, et al.. (2022). Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature. Clinical Medicine Insights Oncology. 16. 1353193840–1353193840. 1 indexed citations
5.
6.
Li, Yingzi, Bo Chen, Xiaoyi Lin, et al.. (2022). Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern. Frontiers in Oncology. 12. 830124–830124. 4 indexed citations
7.
8.
Li, Kai, Li Cao, Cheukfai Li, et al.. (2022). Genomic alteration profile and PD‐L1 expression among different breast cancer subtypes in Chinese population and their correlations. Cancer Medicine. 12(5). 5195–5208. 2 indexed citations
9.
Zhang, Guochun, Chongyang Ren, Cheukfai Li, et al.. (2022). Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status. BMC Medicine. 20(1). 142–142. 90 indexed citations
10.
Jia, Minghan, Ning Liao, Bo Chen, et al.. (2021). PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing. Breast Cancer. 28(3). 644–652. 8 indexed citations
11.
Wen, Lingzhu, Guochun Zhang, Chongyang Ren, et al.. (2021). Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients. Cancer Management and Research. Volume 13. 3055–3065. 5 indexed citations
12.
Lai, Jianguo, et al.. (2021). CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients. Journal of Cellular and Molecular Medicine. 25(19). 9390–9401. 12 indexed citations
13.
Chen, Bo, Liping Guo, Kai Li, et al.. (2021). Association of Body Mass Index With Somatic Mutations in Breast Cancer. Frontiers in Oncology. 11. 613933–613933. 1 indexed citations
14.
Gao, Qiang, Hsiaopei Mok, Hongyu Zhang, et al.. (2021). Inflammatory indicator levels in patients undergoing aortic valve replacement via median sternotomy with preoperative anxiety and postoperative complications: a prospective cohort study. Journal of International Medical Research. 49(2). 1220776969–1220776969. 7 indexed citations
15.
Chen, Bo, Guochun Zhang, Guangnan Wei, et al.. (2020). Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Endocrine Related Cancer. 27(3). 153–162. 26 indexed citations
16.
Chen, Bo, Guochun Zhang, Xuerui Li, et al.. (2020). Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer. Aging. 12(4). 3140–3155. 36 indexed citations
17.
Lai, Jianguo, Bo Chen, Guochun Zhang, et al.. (2020). Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature. Journal of Translational Medicine. 18(1). 416–416. 22 indexed citations
18.
Gao, Qiang, Hsiaopei Mok, & Jian Zhuang. (2019). Secreted modular calcium-binding proteins in pathophysiological processes and embryonic development. Chinese Medical Journal. 132(20). 2476–2484. 24 indexed citations
19.
Mok, Hsiaopei, et al.. (2018). Decreased serum estrogen improves fat graft retention by enhancing early macrophage infiltration and inducing adipocyte hypertrophy. Biochemical and Biophysical Research Communications. 501(1). 266–272. 25 indexed citations
20.
Gao, Qiang, et al.. (2013). Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: A meta-analysis. Oncology Letters. 7(2). 349–356. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth C. O’Quinn Breakdown of academic impact, for papers by W. Shannon Orr Breakdown of academic impact, for papers by Maj‐Lis Talman Breakdown of academic impact, for papers by Young-Joon Ryu Breakdown of academic impact, for papers by Chengjuan Fan Breakdown of academic impact, for papers by Mengzhu Lv Breakdown of academic impact, for papers by Kevin Anton Breakdown of academic impact, for papers by Simon F. Leicht Breakdown of academic impact, for papers by Zhilan Xiao
Rankless by CCL
2026